Your search returned 2 results.

Results
	1.	Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients. MedStar authors: Weissman, Neil J PMID: 30145941 Year: 2018 Citation: New England Journal of Medicine. 379(12):1107-1117, 2018 09 20. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Bohula EA, Bonaca MP, Brown C, Budaj A, CAMELLIA-TIMI 61 Steering Committee and Investigators, Dhadda S, Fanola CL, Francis B, Garcia-Castillo A, Gupta M, Im K, Inzucchi SE, Keech AC, Kuder J, Leiter LA, McGuire DK, Miao W, Patel T, Perdomo C, Qamar A, Ruff CT, Sabatine MS, Scirica BM, Smith SR, Weissman NJ, White HD, Wiviott SD DOI: https://dx.doi.org/10.1056/NEJMoa1808721 Add to cart (remove)
	2.	A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data. MedStar authors: Aroda, Vanita R PMID: 28939018 Year: 2017 Citation: Journal of Diabetes & its Complications. 31(12):1719-1727, 2017 Dec. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Gourgari E, Hassanzadeh H, Shoulson I, Wilhelm EE DOI: https://dx.doi.org/10.1016/j.jdiacomp.2017.08.005 Add to cart (remove)

Refine your search